Innovision IPO Day 2: Issue sees tepid demand as GMP remains weak. Should you apply or not?

-33

Market Impact Score

-100 Bearish+100 Bullish

AI Analysis

The broader market has seen significant volatility recently, with the Sensex crashing, which could be contributing to the cautious investor sentiment towards new IPOs like Innovision. This contrasts with some positive news in the auto sector, but Innovision's specific offering lacks appeal.

Trading Insight

For IPOs with zero or negative GMP, a 'wait and watch' approach post-listing is advisable, or outright avoidance for short-term gains.

Quick check: SENSEX neutral, MARUTI bearish bias (+2.9% 1d).

Key Evidence

•Innovision IPO GMP today is nil.
•Shares of Innovision are trading at par with the IPO price.
•Innovision IPO listing price will be the same as the offer price.
•Shares are slated to list on both BSE and NSE on March 17.
•Risk flag: Weak broader market sentiment impacting new listings.

Affected Stocks

Innovision

Negative

Tepid demand and zero GMP indicate poor investor interest and no expected listing gains.

AI-powered analysis by

Anadi Algo News